For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer of diabetics: heart attacks, strokes and other cardiovascular damage. Preventing those is a long-elusive goal for the millions of diabetes patients and their doctors, and one analyst who's also a trained physician even called Thursday's news of a possible groundbreaking advance a "holy grail."